Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis - Related Videos
07:00
Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
0 Views •
Cited by 8 •
2016
Cognitive deficits are common in about one third of patients with amyotrophic lateral sclerosis, a neurological condition leading to progressive impairments in speech and movement abilities. To conduct cognitive tests in patients unable to speak or write a reliable and easy to administer eye-tracking paradigm was developed.
08:16
Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
0 Views •
Cited by 12 •
2014
Dissociated atrophy of intrinsic hand muscles, termed the split hand, appears to be a specific feature of amyotrophic lateral sclerosis (ALS). Consequently, a novel neurodiagnostic test, termed the split hand index, was developed to quantify the clinical phenomenon of the split hand, which differentiated ALS from mimic disorders.
12:43
A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)
0 Views •
Cited by 40 •
2011
Objective assessments of the physiological mechanisms that support speech are needed to monitor disease onset and progression in persons with ALS and to quantify treatment effects in clinical trials. In this video, we present a comprehensive, instrumentation-based protocol for quantifying speech motor performance in clinical populations.
08:27
Evaluation of Motor Impairment in C. elegans Models of Amyotrophic Lateral Sclerosis
0 Views •
Cited by 9 •
2021
This protocol describes two sensitive assays for discriminating among mild, moderate, and severe motor impairment in C. elegans models of amyotrophic lateral sclerosis, with general utility for C. elegans strains, with altered motility.
12:35
Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)
0 Views •
Cited by 20 •
2012
A mouse model for amyotrophic lateral sclerosis (ALS) is examined clinically and behaviorally. As a prerequisite for an accompanying immunohistological analysis the preparation of the spinal cord is depicted in detail.
FAQs
Abnormally activated microglia and astrocytes may alter the environment surrounding motor neurons by releasing inflammatory signals. These signals do not simply mark existing damage; they can influence the extent of neuronal injury, making glial responses a possible contributor to disease progression. This mechanism gives ALS research an immune-mediated dimension beyond the intrinsic vulnerability of neurons.
Immune dysregulation may connect cellular inflammation with the progressive loss of motor-neuron function. However, current information does not establish a single immune pathway or show whether immune changes initiate, amplify, or accompany neuronal damage. Researchers therefore examine immune responses as part of a broader disease mechanism rather than treating them as a complete explanation.
Possible interactions with infectious or environmental factors remain unresolved in ALS. Their importance lies in the possibility that outside influences could affect immune regulation or glial activation, thereby changing neuronal injury. Because these relationships are still being investigated, they should be treated as research questions rather than confirmed causes, and they may help explain variation in disease mechanisms.
Mechanistic studies can link motor-neuron dysfunction, glial activation, inflammatory signaling, and immune dysregulation with measurable biological indicators. Such biomarkers could help researchers track disease-related processes and evaluate whether an intervention changes them. Their value also includes clarifying which biological events accompany neuronal injury and supporting the development of therapies directed at relevant disease mechanisms.
These mechanisms point toward three broad therapeutic aims: protecting motor neurons, regulating harmful immune responses, and preserving remaining function. The rationale is to address both neuronal vulnerability and the inflammatory environment shaped by glial cells. Because the underlying relationships remain under study, these aims describe research directions rather than guaranteed treatments or established clinical outcomes.
ALS is relevant to this field because its progression includes abnormal glial activation, inflammatory signaling, and immune dysregulation, while possible infectious interactions remain an open question. This connection encourages researchers to examine how immune responses relate to motor-neuron injury without reducing ALS to an infectious disease. The subject context therefore broadens investigation of neurodegeneration.